Unknown

Dataset Information

0

Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients.


ABSTRACT: Kidney transplant recipients (KTRs) abnormally replicate the Epstein Barr Virus (EBV). To better understand how long-term immunosuppression impacts the immune control of this EBV re-emergence, we systematically compared 10 clinically stable KTRs to 30 healthy controls (HCs). The EBV-specific T cell responses were determined in both groups by multiparameter flow cytometry with intra cellular cytokine staining (KTRs n = 10; HCs n = 15) and ELISpot-IFN? assays (KTRs n = 7; HCs n = 7). The T/B/NK cell counts (KTRs n = 10; HCs n = 30) and the NK/T cell differentiation and activation phenotypes (KTRs n = 10; HCs n = 15/30) were also measured. We show that in KTRs, the Th1 effector CD4+ T cell responses against latent EBV proteins are weak (2/7 responders). Conversely, the frequencies total EBV-specific CD8+T cells are conserved in KTRs (n = 10) and span a wider range of EBNA-3A peptides (5/7responders) than in HCs (5/7responders). Those modifications of the EBV-specific T cell response were associated with a profound CD4+ T cell lymphopenia in KTRs compared to HCs, involving the naïve CD4+ T cell subset, and a persistent activation of highly-differentiated senescent CD8+ T cells. The proportion of total NK / CD8+ T cells expressing PD-1 was also increased in KTRs. Noteworthy, PD-1 expression on CD8+ T cells normalized with time after transplantation. In conclusion, we show modifications of the EBV-specific cellular immunity in long term transplant recipients. This may be the result of both persistent EBV antigenic stimulation and profound immunosuppression induced by anti-rejection treatments. These findings provide new insights into the immunopathology of EBV infection after renal transplantation.

SUBMITTER: Nakid-Cordero C 

PROVIDER: S-EPMC6804993 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients.

Nakid-Cordero Cecilia C   Arzouk Nadia N   Gauthier Nicolas N   Tarantino Nadine N   Larsen Martin M   Choquet Sylvain S   Burrel Sonia S   Autran Brigitte B   Vieillard Vincent V   Guihot Amélie A  

PloS one 20191022 10


Kidney transplant recipients (KTRs) abnormally replicate the Epstein Barr Virus (EBV). To better understand how long-term immunosuppression impacts the immune control of this EBV re-emergence, we systematically compared 10 clinically stable KTRs to 30 healthy controls (HCs). The EBV-specific T cell responses were determined in both groups by multiparameter flow cytometry with intra cellular cytokine staining (KTRs n = 10; HCs n = 15) and ELISpot-IFNγ assays (KTRs n = 7; HCs n = 7). The T/B/NK ce  ...[more]

Similar Datasets

| S-EPMC5175232 | biostudies-other
| S-EPMC6650320 | biostudies-literature
| S-EPMC6947615 | biostudies-literature
| S-EPMC5461791 | biostudies-literature
| PRJNA1054489 | ENA
| S-EPMC6727270 | biostudies-literature
2024-10-15 | GSE250536 | GEO
| S-EPMC7447038 | biostudies-literature
| S-EPMC6829185 | biostudies-literature
| S-EPMC7859872 | biostudies-literature